Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
3 min read
Biogen's tau-targeted antisense oligonucleotide therapy shows positive clinical data in the treatment of Alzheimer's disease
30 October 2023
Recently, Biogen announced positive results from the Phase 1b trial of BIIB080, an investigational antisense oligonucleotide (ASO) therapy targeting tau protein for the treatment of mild Alzheimer's Disease (AD).
Drug Insights
4 min read
Unleashing the Power of Benazepril Hydrochloride: A Comprehensive Review on R&D Breakthroughs
30 October 2023
This article summarized the latest R&D progress of Benazepril Hydrochloride, the Mechanism of Action for Benazepril Hydrochloride, and the drug target R&D trends for Benazepril Hydrochloride.
Bio Sequence
2 min read
Biological Glossary | What is Coding Sequence (CDS)?
30 October 2023
A coding sequence (CDS) is a portion of a gene or an mRNA molecule that specifically codes for a protein.
Drug Insights
4 min read
A Comprehensive Review of Belantamab mafodotin's R&D Innovations and Drug Target Mechanism
30 October 2023
This article summarized the latest R&D progress of Belantamab mafodotin, the Mechanism of Action for Belantamab mafodotin, and the drug target R&D trends for Belantamab mafodotin.
Latest Hotspot
3 min read
Immatics TCR-T therapy IMA203 is granted RMAT designation by CBER for the treatment of multiple types of cancer
30 October 2023
Recently, Immatics announced that its T cell receptor T cell (TCR-T) therapy IMA203 under research has been granted the Regenerative Medicine Advanced Therapy (RMAT) designation by the Center for Biologics Evaluation and Research (CBER) of the U.S. FDA.
Drug Insights
4 min read
Pharmaceutical Insights: Baloxavir Marboxil's R&D Progress and its Mechanism of Action on Drug Target
30 October 2023
This article summarized the latest R&D progress of Baloxavir Marboxil, the Mechanism of Action for Baloxavir Marboxil, and the drug target R&D trends for Baloxavir Marboxil.
Bio Sequence
3 min read
The Evolution of Competitive Landscape Behind the Best Pharmaceutical Agent Tirzepatide in 2023
30 October 2023
Exploring the changes occurring within the application structure amongst Tirzepatide's top 10 patent assignees over time delivers insights into the competitive landscape's evolution.
Drug Insights
4 min read
Betamethasone Sodium Phosphate: Detailed Review of its Transformative R&D Success
27 October 2023
This article summarized the latest R&D progress of Betamethasone Sodium Phosphate, the mechanism of action for Betamethasone Sodium Phosphate, and the drug target R&D trends for Betamethasone Sodium Phosphate.
Latest Hotspot
3 min read
Anshi Biotechnology's small molecule selective MET inhibitor, Bozitinib, has applied for marketing for a new indication, the treatment of gliomatosis cerebri
27 October 2023
On Oct 24, 2023, China's CDE announced that Purunao Biotechnology, a subsidiary of Anshi Biotechnology, applied to list a new indication for the Class 1 new drug Vebreltinib on their official website.
Drug Insights
5 min read
Pharmaceutical Insights: toremifene citrate's R&D Progress and its Mechanism of Action on Drug Target
27 October 2023
This article summarized the latest R&D progress of toremifene citrate, the Mechanism of Action for toremifene citrate, and the drug target R&D trends for toremifene citrate.
Bio Sequence
3 min read
Contemporary Competitive Scenario: Analyzing Roche's Emergent Product, Trontinemab
27 October 2023
Exploring the changes occurring within the application structure amongst Trontinemab's top 10 patent assignees over time delivers insights into the competitive landscape's evolution.
Drug Insights
5 min read
Exploring treosulfan's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
27 October 2023
This article summarized the latest R&D progress of treosulfan, the Mechanism of Action for treosulfan, and the drug target R&D trends for treosulfan.